DYN
DYN
US26818M1080
Dyne Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
468.184.000 343.886.000
36.1%
Operating Income -468.184.000 -343.886.000
36.1%
Pretax Income -446.214.000 -317.418.000
40.6%
Net Income Common Stockholders -446.214.000 -317.418.000
40.6%
-- --
--
-- --
--
ende